Correction: Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population

Correction: Polymorphisms in the mTOR Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population

Bibliographic Details
Main Authors:	Qiaoxin Li, Chengyuan Gu, Yao Zhu, Mengyun Wang, Yajun Yang, Jiucun Wang, Li Jin, Mei-Ling Zhu, Ting-Yan Shi, Jing He, Xiaoyan Zhou, Ding-wei Ye, Qingyi Wei
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882253/?tool=EBI

Similar Items

Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population.
by: Qiaoxin Li, et al.
Published: (2013-01-01)

Correction: Polymorphisms in the Gene and Risk of Sporadic Prostate Cancer in an Eastern Chinese Population.
by: Qiaoxin Li, et al.
Published: (2014-01-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

mTOR inhibition as a therapeutic strategy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
by: Davies, David Mark
Published: (2011)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
by: Tian Tian, et al.
Published: (2019-02-01)

mTOR signaling pathway and mTOR inhibitors in the treatment of cancer
by: Mehmet Küçüköner, et al.
Published: (2013-03-01)

Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
by: Jiawei Chen, et al.
Published: (2012-01-01)

TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
by: Jin Koo Kim, et al.
Published: (2013-09-01)

Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies
by: Jing-Wei Lyu, et al.
Published: (2019-04-01)

Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis
by: Isabel Gugel, et al.
Published: (2020-01-01)

The prognostic role of mTOR and p-mTOR for survival in non-small cell lung cancer: a systematic review and meta-analysis.
by: Lei Li, et al.
Published: (2015-01-01)

Role of mTOR Complexes in Neurogenesis
by: Francesca LiCausi, et al.
Published: (2018-05-01)

Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.
by: Jianbo Shao, et al.
Published: (2014-01-01)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
by: Kerstin Tiedemann, et al.
Published: (2017-05-01)

mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
by: Zhuo Wang, et al.
Published: (2014-01-01)

Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer
by: Giorgio Ivan Russo, et al.
Published: (2019-01-01)

MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
by: Nicola J Clegg, et al.
Published: (2011-03-01)

Roles of mTOR Signaling in Tissue Regeneration
by: Xiangyong Wei, et al.
Published: (2019-09-01)

mTOR Signaling in Metabolic Stress Adaptation
by: Cheng-Wei Wu, et al.
Published: (2021-05-01)

Targeting mTOR for cancer therapy
by: Hui Hua, et al.
Published: (2019-07-01)

Role of Yanghe Huayan Decoction in ER-PI3K/Akt/mTOR pathway of endocrine-resistant breast cancer cells with low mTOR expression
by: Xue Sun, et al.
Published: (2020-07-01)

mTOR, autophagy and reprogramming
by: Bor Luen eTang
Published: (2014-01-01)

mTOR and Tumor Cachexia
by: Adrian P. Duval, et al.
Published: (2018-07-01)

mTOR in Human Diseases
by: Olivier Dormond
Published: (2019-05-01)

mTOR in Human Diseases
Published: (2019)

Moxibustion Improves Chronic Heart Failure by Inhibiting Autophagy and Inflammation via Upregulation of mTOR Expression
by: Qingling Li, et al.
Published: (2021-01-01)

Oridonin inhibits metastasis of human ovarian cancer cells by suppressing the mTOR pathway
by: Ye Wang, et al.
Published: (2018-07-01)

miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells
by: Yun Ye, et al.
Published: (2020-12-01)

Activation of mTOR ameliorates fragile X premutation rCGG repeat-mediated neurodegeneration.
by: Yunting Lin, et al.
Published: (2013-01-01)

Targeting of the PI3K/AKT/mTOR pathway in human prostate cancer
by: Butler, Dominika Ewelina
Published: (2014)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
by: Guo-Dong Cao, et al.
Published: (2016-01-01)

mTOR complexes differentially orchestrates eosinophil development in allergy
by: Chen Zhu, et al.
Published: (2018-05-01)

AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
by: Ying Wang, et al.
Published: (2020-12-01)

A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.
by: Ming Xu, et al.
Published: (2013-01-01)

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Tanjala T. Gipson, et al.
Published: (2012-01-01)

Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
by: Zhou Zhu, et al.
Published: (2019-02-01)

Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer.
by: Sabrina T Reis, et al.
Published: (2016-01-01)

Activation of the mTOR signaling pathway is required for asthma onset
by: Yanli Zhang, et al.
Published: (2017-07-01)

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
by: Ning Ma, et al.
Published: (2021-05-01)

Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population.
by: Mengyun Wang, et al.
Published: (2012-01-01)

Cannot write session to /tmp/vufind_sessions/sess_n30vsfl5m1i7un0ialq3pionh9